These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34309530)

  • 21. Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine.
    Sy MY; Fromm E; Doan L; Rojek N; Brandt AU
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34759023
    [No Abstract]   [Full Text] [Related]  

  • 22. Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
    Terpos E; Trougakos IP; Gavriatopoulou M; Papassotiriou I; Sklirou AD; Ntanasis-Stathopoulos I; Papanagnou ED; Fotiou D; Kastritis E; Dimopoulos MA
    Blood; 2021 Jul; 137(26):3674-3676. PubMed ID: 33861315
    [No Abstract]   [Full Text] [Related]  

  • 23. What constitutes success in the roll-out of COVID-19 vaccines?
    Smith MJ
    Lancet; 2021 Jul; 398(10295):115-116. PubMed ID: 34181882
    [No Abstract]   [Full Text] [Related]  

  • 24. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
    Schramm R; Costard-Jäckle A; Rivinius R; Fischer B; Müller B; Boeken U; Haneya A; Provaznik Z; Knabbe C; Gummert J
    Clin Res Cardiol; 2021 Aug; 110(8):1142-1149. PubMed ID: 34241676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.
    Gallagher ME; Sieben AJ; Nelson KN; Kraay ANM; Orenstein WA; Lopman B; Handel A; Koelle K
    Nat Med; 2021 Jan; 27(1):4-5. PubMed ID: 33230343
    [No Abstract]   [Full Text] [Related]  

  • 26. Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.
    Teles M; Connolly CM; Frey S; Chiang TP; Alejo JL; Boyarsky BJ; Shah AA; Albayda J; Christopher-Stine L; Werbel WA; Segev DL; Paik JJ
    Ann Rheum Dis; 2022 May; 81(5):738-740. PubMed ID: 35039324
    [No Abstract]   [Full Text] [Related]  

  • 27. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 28. Intradermal covid-19 vaccination could solve supply problems.
    Schweiger M
    BMJ; 2021 Aug; 374():n1980. PubMed ID: 34400478
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter to the editor: COVID-19 Vaccines and Breastfeeding.
    Saus-Ortega C
    J Hum Lact; 2021 May; 37(2):273-274. PubMed ID: 33576702
    [No Abstract]   [Full Text] [Related]  

  • 30. Priority setting during the COVID-19 pandemic: going beyond vaccines.
    Williams I; Essue B; Nouvet E; Sandman L; Razavi SD; Noorulhuda M; Goold S; Danis M; Biemba G; Abelson J; Kapiriri L
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33461979
    [No Abstract]   [Full Text] [Related]  

  • 31. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.
    Med Lett Drugs Ther; 2021 May; 63(1624):e1. PubMed ID: 33976095
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccinating healthcare workers against covid-19.
    Shemtob L; Ferris M; Asanati K; Majeed A
    BMJ; 2021 Aug; 374():n1975. PubMed ID: 34380668
    [No Abstract]   [Full Text] [Related]  

  • 33. Inadvertent subcutaneous injection of COVID-19 vaccine.
    Ng JY
    Postgrad Med J; 2021 Jun; 97(1148):400. PubMed ID: 33589486
    [No Abstract]   [Full Text] [Related]  

  • 34. Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations.
    Waldman RA; Grant-Kels JM
    J Am Acad Dermatol; 2021 Nov; 85(5):1113-1116. PubMed ID: 34437985
    [No Abstract]   [Full Text] [Related]  

  • 35. [COVID-19 vaccines increase the risk of anaphylaxis].
    Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
    Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vaccination and Vaccination Response in Immunodeficiency].
    Rohner GB; Jandus P
    Ther Umsch; 2022 Aug; 79(6):307-311. PubMed ID: 35903827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Compensation and COVID-19 Vaccines.
    Trogen B; Caplan A
    Ann Intern Med; 2021 Jun; 174(6):858-859. PubMed ID: 33646837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of COVID-19 vaccines in immunocompromised patients.
    Negahdaripour M; Shafiekhani M; Moezzi SMI; Amiri S; Rasekh S; Bagheri A; Mosaddeghi P; Vazin A
    Int Immunopharmacol; 2021 Oct; 99():108021. PubMed ID: 34352567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus on disease control objectives in the context of COVID-19 vaccines.
    Jain V; Tweed S
    Bull World Health Organ; 2021 May; 99(5):322. PubMed ID: 33958816
    [No Abstract]   [Full Text] [Related]  

  • 40. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.